Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-04-16Clinical Trial Update: TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma [Phase 3]
A Phase 3 clinical trial compares transarterial chemoembolization plus radiofrequency ablation (TACE+RFA) against re-resection for recurrent…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
A terminated clinical trial evaluated whether Sorafenib or Regorafenib affects P63 expression and keratinocyte differentiation in human skin…
-
CLINICAL_TRIALS research · 2013-04-12Clinical Trial Update: A Study of DC-CIK to Treat Hepatocellular Carcinoma [Phase 2]
This document reports a Phase 2 clinical trial update of DC-CIK therapy for hepatocellular carcinoma, with the trial status currently listed…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma [Phase 1]
Phase 1 study assessing the combination of RAD001 (everolimus) and sorafenib in patients with advanced hepatocellular carcinoma has been ter…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 [Phase 2]
Phase 2 study evaluating AMT2003 in patients with advanced hepatocellular carcinoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas [Phase 2]
Phase 2 clinical trial evaluating photodynamic therapy for cancers of the bile duct, gallbladder, liver, and pancreas; the study has complet…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy [Phase 2]
This is a completed Phase 2 trial evaluating tivantinib (ARQ 197) in patients with unresectable hepatocellular carcinoma after failure of on…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [Phase 1]
A Phase 1 trial tested the combination of Interleukin-12 and trastuzumab in HER2/Neu-overexpressing cancers and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
Phase 2 trial evaluating gefitinib in adults with advanced unresectable hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer [Phase 1]
Phase 1 study assessing the safety of combining sorafenib tosylate with chemoembolization in patients with unresectable hepatocellular carci…
-
CLINICAL_TRIALS research · 2013-02-21Clinical Trial Update: Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy
This clinical trial update investigates enumeration and functional analysis of regulatory T cells in peripheral blood of hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Use of N-Acetylcysteine During Liver Procurement [Phase 2]
This ClinicalTrials.gov entry reports the completion of a Phase 2 study evaluating the use of N-acetylcysteine during liver procurement.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [Phase 2]
Phase 2 trial of thalidomide in combination with interferon alfa in patients with unresectable progressive liver cancer (hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [Phase 1]
Phase 1 trial evaluating vaccine therapy with or without sargramostim in patients with advanced or metastatic cancer; the study was complete…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction [Phase 1]
Phase 1 study evaluating Erlotinib in adults with unresectable hepatocellular carcinoma and liver dysfunction has completed, reporting initi…
-
CLINICAL_TRIALS withdrawal · 2013-01-23Clinical Trial Update: Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed [Phase 2]
A phase 2 trial of erlotinib for unresectable hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed [Phase 2]
A Phase 2 clinical trial evaluating Sho-Saiko-To for unresectable hepatocellular carcinoma treated with embolization has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: TK-based Suicide Gene Therapy for Hepatocellular Carcinoma [Phase 1]
Phase 1 study of a thymidine kinase–based suicide gene therapy for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [Phase 1]
Phase 1 clinical trial evaluating erlotinib in patients with solid tumors and liver or kidney dysfunction has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]
This NCI-sponsored clinical trial evaluating EF5 and Motexafin Lutetium for detecting tumor cells in patients with abdominal cancers or non-…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer [Phase 3]
Phase 3 trial comparing sunitinib malate to sorafenib in inoperable hepatocellular carcinoma was terminated with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas [Phase 1]
A Phase 1 clinical trial evaluating chemoembolisation for patients with non-resectable, non-metastatic hepatocellular carcinoma has complete…
-
CLINICAL_TRIALS research · 2013-01-09Clinical Trial Update: Utility Study of Primovist-MRI on HCC Staging
This clinical trial update assesses the utility of Primovist-MRI for staging hepatocellular carcinoma. The study is sponsored by Inha Univer…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. [Phase 1]
This clinical trial update reports the termination of a Phase I study of AZD1480 in patients with advanced solid malignancies and advanced h…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
The Phase 2 trial of ABT-869 in advanced hepatocellular carcinoma has completed.